Part of The Mesothelioma Center. Contact Us
Mesothelioma-Line.com.
Journal Articles on Mesothelioma: Cancer Information for Patients and Families

Archive for the 'Benign' Category

Benign news feed.

December 23rd, 2008. Malignant mesothelioma

Compensation issues must also be considered. Life expectancy in malignant mesothelioma is poor, with a median survival of about one year following diagnosis.

November 6th, 2008. Benign mesothelioma of peritoneum presenting as a pelvic mass

Postoperative recovery was satisfactory. At 3 years follow-up, patient is symptom-free.

November 1st, 2008. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis

5% of malignant mesothelioma versus 92. 5% of adenocarcinoma.

September 30th, 2008. Mesothelial reaction in longstanding Crohn’s ileitis simulating papillary mesothelioma

The peritoneal surface of the ileal resection specimen displayed exuberant tubulo-papillary formations of the mesothelium, with superficial invasion of the underlying stroma. The case demonstrates the well-recognised difficult differential diagnosis between a benign mesothelial proliferation and malignant mesothelioma in a novel clinical setting, and the diversity of the extramural manifestations of Crohn's disease.

June 17th, 2008. Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass

This unusual presentation may point to a traumatic or inflammatory etiology, although seeding of the wound during the previous surgeries is a more likely postulate. A pertinent review of the literature on benign multicystic mesothelioma is also presented.

May 15th, 2008. Cytology of benign multicystic peritoneal mesothelioma in peritoneal washings

Conclusion: The combination of cytology of the peritoneal washing, histology (cell block and surgical specimen) and clinical history allow differentiation of BMPM from other cystic lesions (cystic lymphangioma and malignant mesothelioma).

April 4th, 2008. The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations

Conclusions: Used in combination, Ki-67 and repp86 appear to be useful markers in differentiating MM from benign reactive MH.

February 27th, 2008. I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancer

Extrathyroidal I-131 accumulation has been reported in various sites, such as ectopic gastric mucosa, gastrointestinal and urinary tract abnormalities, cysts (mammary, liver, kidney, and ovaries), and inflammation and infection foci. We report a case of focal I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancer.

October 3rd, 2007. Benign Peritoneal Multicystic Mesothelioma Diagnosed and Treated by Laparoscopic Surgery

In this paper, we present the case of a young woman with benign multicystic mesothelioma in which only laparoscopy led to the appropriate diagnosis. Subsequently, the tumor was removed by laparoscopic surgery.

June 5th, 2007. Benign peritoneal cystic mesothelioma as differential diagnose of an ovarian dependant tumor. Case report and review of the literature

Despite the low incidence of this tumoration the gynecologist must be familiar with this disease, because of the high recurrence. Nowadays, steroid hormone receptors typification seems to play an important role to control the recurrence of this tumoration.

April 19th, 2007. Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells

This finding suggests a major role for an autocrine chemokine pathway in leukocytes but not in MM cells. The increased monocyte infiltration and their higher chemokine receptor expression in MM effusions may have a tumor-promoting rather than tumor-inhibiting effect.

March 30th, 2007. Value of antimesothelioma HBME-1 in the diagnosis of inflammatory and malignant pleural effusions

33%) cases; the staining pattern in metastatic adenocarcinoma cells was thin membrane and focal cytoplasmic. HBME-1 has a moderate sensibility and specificity for mesothelial cells and can be used as part of a panel for differentiation of malignant and reactive mesothelial cells from adenocarcinoma in pleural effusions.

March 23rd, 2007. Asbestos-related lung disease

Because exposure to cigarette smoke increases the risk of developing lung cancer in patients with a history of asbestos exposure, smoking cessation is essential. Patients with asbestosis or lung cancer should receive influenza and pneumococcal vaccinations.

February 13th, 2007. Benign cystic mesothelioma presenting as a huge pelvic mass–a case report

All tumoral markers were within normal range. Surgical [corrected] treatment consisted of radical excision of the mass and the prognosis was good [corrected].

February 3rd, 2007. Asbestos-related diseases

br Abstract This chapter presents a bibliographic review of asbestos-related diseases. The latest diagnostic, radiological, computed tomography and lung function aspects of benign pleural disease, asbestosis, occupational lung cancer and mesothelioma are discussed.

December 14th, 2006. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports

Conclusions: Immunohistochemistry is of limited value, but newer diagnostic methods may be useful additions in this area of pathology. The diagnostic importance of histological features seen on plain tissue sections is emphasized as vital for correctly differentiating between benign pleural disease and malignant pleural mesothelioma.

November 1st, 2006. Solitary fibrous tumor of the pleura

Conclusions: Benign SFTP has a high cure rate and an 8% local recurrence rate that is usually amenable to curative re-excision. Malignant SFTP, especially the more common sessile type, has a 63% recurrence rate even with complete resection. The majority of patients with recurrent disease die of the tumor within 2 years. Nevertheless, the overall long-term cure rate for all patients is 88% to 92%.

September 29th, 2006. Benign multicystic peritoneal mesothelioma: A case report and review of the literature

Complete resection of the lesion was performed. The patient had an uneventful recovery and had no recurrence two years after surgery.

July 24th, 2006. Multilocular peritoneal inclusion cyst – a case report

We report a case of a 26-year old female who underwent Caesarean section during which cysts which were multiloculated, thin-walled and filled with serous fluid, were incidentally discovered. Its histopathologic examination established the diagnosis.

July 19th, 2006. Imaging of pleural disease

The conditions covered include benign and malignant pleural thickening, pleural effusions, empyema and pneumothoraces. The relative merits of CT, MRI and PET in the assessment of these conditions and the role of image-guided intervention are discussed.